Showing results (531-540 of 2,330) with videos related to
Sort By:
Pageof 233
Clinical Drug Investigation|November 8, 2023
Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled TrialsXiaojuan Jiao, Ping Peng, Qin Zhang, et al.Clinical Drug Investigation|November 17, 2023
Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2- Advanced Breast Cancer in the USA?Wenhua Wu, Huiting Lin, Jiaqin Cai, et al.Clinical Drug Investigation|November 8, 2023
Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysisJulyana Medeiros Dantas, Mariana de Jesus Oliveira, Luciana Alves Oliveira Silva, et al.Clinical Drug Investigation|October 2, 2024
Single‑Dose Pharmacokinetics and Safety of the Oral Galectin‑3 Inhibitor, Selvigaltin (GB1211), in Participants with Hepatic ImpairmentVassilios Aslanis, Michael Gray, Robert J Slack, et al.Clinical Drug Investigation|February 24, 2026
Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective StudyMichela Starace, Francesca Pampaloni, Federico Quadrelli, et al.Clinical Drug Investigation|November 28, 2024
Evaluation of the Effectiveness of Additional Risk Minimisation Measures for Tofacitinib (Xeljanz®) in Europe: A Prescriber SurveyJoanne Wu, Nana Koram, Kofi Asomaning, et al.Clinical Drug Investigation|May 29, 2026
Effectiveness of Micronized Purified Flavonoid Fraction on Quality of Life in Patients with Chronic Venous Disease: A Systematic Review and Meta-analysisFabricio Rodrigues Santiago, Denisa Celovska, Sarah Thomis, et al.Clinical Drug Investigation|May 16, 2026
Assessing the Completeness of Adverse Event Reporting in Clinical Trials of Psoriasis Treatments: A Registry-Publication Comparison StudyMadeline Rowe, Madison Dinh, Ryan Sherry, et al.Clinical Drug Investigation|March 15, 2026
Effectiveness and Tolerability of Vortioxetine in Major Depressive Disorder: A Real-World Study in SwitzerlandMartin Kammerer, Gregor Hasler, Barbara Hochstrasser, et al.Clinical Drug Investigation|March 13, 2026
Cost Effectiveness of First-Line Therapies for Treatment-Naïve Chronic Lymphocytic Leukaemia in South AfricaRochelle Woudberg, Edina SinanovicPageof 233